CN100402074C - A Chinese medicinal ointment for promoting wound healing after anal fistula operation and preparation method thereof - Google Patents
A Chinese medicinal ointment for promoting wound healing after anal fistula operation and preparation method thereof Download PDFInfo
- Publication number
- CN100402074C CN100402074C CNB2006100438187A CN200610043818A CN100402074C CN 100402074 C CN100402074 C CN 100402074C CN B2006100438187 A CNB2006100438187 A CN B2006100438187A CN 200610043818 A CN200610043818 A CN 200610043818A CN 100402074 C CN100402074 C CN 100402074C
- Authority
- CN
- China
- Prior art keywords
- group
- chinese medicine
- medicine
- processed
- calculus bovis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002674 ointment Substances 0.000 title claims abstract description 33
- 230000029663 wound healing Effects 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 208000004680 Rectal Fistula Diseases 0.000 title claims description 31
- 206010002156 anal fistula Diseases 0.000 title claims description 31
- 230000001737 promoting effect Effects 0.000 title abstract description 18
- 239000003814 drug Substances 0.000 claims abstract description 101
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 31
- 241001161070 Calomela Species 0.000 claims abstract description 21
- 238000012545 processing Methods 0.000 claims abstract description 6
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 22
- 239000011812 mixed powder Substances 0.000 claims description 21
- 239000009286 sanguis draxonis Substances 0.000 claims description 21
- 241000717739 Boswellia sacra Species 0.000 claims description 18
- 239000004863 Frankincense Substances 0.000 claims description 18
- 244000293323 Cosmos caudatus Species 0.000 claims description 17
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 17
- 241001057584 Myrrha Species 0.000 claims description 17
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 15
- 238000005303 weighing Methods 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000000758 substrate Substances 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 4
- 230000002829 reductive effect Effects 0.000 claims description 4
- 238000004587 chromatography analysis Methods 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 239000004570 mortar (masonry) Substances 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 239000003871 white petrolatum Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 41
- 206010052428 Wound Diseases 0.000 abstract description 31
- 208000027418 Wounds and injury Diseases 0.000 abstract description 31
- 208000014617 hemorrhoid Diseases 0.000 abstract description 19
- 230000017531 blood circulation Effects 0.000 abstract description 6
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract description 6
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract description 6
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract description 5
- 229940116229 borneol Drugs 0.000 abstract description 5
- 239000000835 fiber Substances 0.000 abstract description 5
- 208000015181 infectious disease Diseases 0.000 abstract description 5
- 230000008030 elimination Effects 0.000 abstract description 3
- 238000003379 elimination reaction Methods 0.000 abstract description 3
- 230000006872 improvement Effects 0.000 abstract description 3
- 235000000177 Indigofera tinctoria Nutrition 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 239000003102 growth factor Substances 0.000 abstract description 2
- 229940097275 indigo Drugs 0.000 abstract description 2
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 abstract description 2
- 230000004089 microcirculation Effects 0.000 abstract description 2
- 206010016717 Fistula Diseases 0.000 abstract 3
- 230000003890 fistula Effects 0.000 abstract 3
- 230000001133 acceleration Effects 0.000 abstract 2
- 206010004542 Bezoar Diseases 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 241000935235 Fritillaria meleagris Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 241000238371 Sepiidae Species 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 229940105847 calamine Drugs 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 229910052602 gypsum Inorganic materials 0.000 abstract 1
- 239000010440 gypsum Substances 0.000 abstract 1
- 229910052864 hemimorphite Inorganic materials 0.000 abstract 1
- 230000006798 recombination Effects 0.000 abstract 1
- 238000005215 recombination Methods 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 235000014692 zinc oxide Nutrition 0.000 abstract 1
- 239000011787 zinc oxide Substances 0.000 abstract 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 19
- 230000036407 pain Effects 0.000 description 19
- 230000035876 healing Effects 0.000 description 17
- 206010040943 Skin Ulcer Diseases 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 13
- 231100000019 skin ulcer Toxicity 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 230000008961 swelling Effects 0.000 description 11
- 206010042674 Swelling Diseases 0.000 description 10
- 238000005469 granulation Methods 0.000 description 10
- 230000003179 granulation Effects 0.000 description 10
- 231100000614 poison Toxicity 0.000 description 9
- 208000025865 Ulcer Diseases 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 230000036461 convulsion Effects 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000002980 postoperative effect Effects 0.000 description 8
- 206010010904 Convulsion Diseases 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- 239000003440 toxic substance Substances 0.000 description 7
- 231100000397 ulcer Toxicity 0.000 description 7
- 201000004624 Dermatitis Diseases 0.000 description 6
- 208000033809 Suppuration Diseases 0.000 description 6
- 206010040872 skin infection Diseases 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 241000475481 Nebula Species 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 239000002390 adhesive tape Substances 0.000 description 4
- 208000002399 aphthous stomatitis Diseases 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 206010015037 epilepsy Diseases 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 3
- 206010002153 Anal fissure Diseases 0.000 description 3
- 208000016583 Anus disease Diseases 0.000 description 3
- 206010010071 Coma Diseases 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 240000001624 Espostoa lanata Species 0.000 description 3
- 235000009161 Espostoa lanata Nutrition 0.000 description 3
- 208000009531 Fissure in Ano Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 229920000153 Povidone-iodine Polymers 0.000 description 3
- 208000002847 Surgical Wound Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 210000002808 connective tissue Anatomy 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 210000003026 hypopharynx Anatomy 0.000 description 3
- 229960001621 povidone-iodine Drugs 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010048946 Anal abscess Diseases 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 241000208229 Burseraceae Species 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000201295 Euphrasia Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010020741 Hyperpyrexia Diseases 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 241000382362 Persicaria tinctoria Species 0.000 description 2
- 241000879903 Pteria Species 0.000 description 2
- 241001663378 Sepiella maindroni Species 0.000 description 2
- 241000191963 Staphylococcus epidermidis Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 210000000436 anus Anatomy 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000009172 bursting Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- -1 cholochrome Chemical compound 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 238000002692 epidural anesthesia Methods 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000001473 noxious effect Effects 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 235000015170 shellfish Nutrition 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000003371 toe Anatomy 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 229910000010 zinc carbonate Inorganic materials 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- OPFTUNCRGUEPRZ-UHFFFAOYSA-N (+)-beta-Elemen Natural products CC(=C)C1CCC(C)(C=C)C(C(C)=C)C1 OPFTUNCRGUEPRZ-UHFFFAOYSA-N 0.000 description 1
- OPFTUNCRGUEPRZ-QLFBSQMISA-N (-)-beta-elemene Chemical compound CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 1
- DSSRNNGLLCLIPR-QHGLUPRGSA-N (2s)-2-amino-n-(1,2,3,4-tetrahydronaphthalen-2-yl)propanamide Chemical compound C1=CC=C2CC(NC(=O)[C@@H](N)C)CCC2=C1 DSSRNNGLLCLIPR-QHGLUPRGSA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CJGSNPCDEYCMDA-UHFFFAOYSA-N 2-[(dimethylamino)methyl]-4-fluoro-6-methylphenol Chemical compound CN(C)CC1=CC(F)=CC(C)=C1O CJGSNPCDEYCMDA-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- PFCVZKFJHRCLCC-MTYXOXLRSA-N Alphitolic acid Natural products CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@@H](CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O PFCVZKFJHRCLCC-MTYXOXLRSA-N 0.000 description 1
- 206010065360 Anal prolapse Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- GWZYPXHJIZCRAJ-UHFFFAOYSA-N Biliverdin Natural products CC1=C(C=C)C(=C/C2=NC(=Cc3[nH]c(C=C/4NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O GWZYPXHJIZCRAJ-UHFFFAOYSA-N 0.000 description 1
- RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 description 1
- 241001608538 Boswellia Species 0.000 description 1
- 235000018062 Boswellia Nutrition 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 229910021532 Calcite Inorganic materials 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000382825 Cristaria plicata Species 0.000 description 1
- 241001172538 Daemonorops draco Species 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 241000123611 Dipterocarpaceae Species 0.000 description 1
- UFJPCTSKTPSJTK-UHFFFAOYSA-N Dryobalanone Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC(C(O)(CO)CCC=C(C)C)C4CCC3C21C UFJPCTSKTPSJTK-UHFFFAOYSA-N 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 241000605372 Fritillaria Species 0.000 description 1
- 241001644297 Fritillaria delavayi Species 0.000 description 1
- 241001644295 Fritillaria przewalskii Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 244000153234 Hibiscus abelmoschus Species 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 241000382840 Hyriopsis cumingii Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- OVHUAFPHYGFWPY-UHFFFAOYSA-N Imperialin Natural products CC1CN2CC3C(CCC4C3CC5C4CC(=O)C6CC(O)CCC56C)CC2C(C)(O)C1 OVHUAFPHYGFWPY-UHFFFAOYSA-N 0.000 description 1
- IQDIERHFZVCNRZ-LZOOXBQUSA-N Imperialine Natural products O=C1[C@@H]2[C@@](C)([C@@H]3[C@H]([C@@H]4[C@H]([C@H]5[C@H]([C@@](O)(C)[C@H]6N(C[C@@H](C)CC6)C5)CC4)C3)C1)CC[C@@H](O)C2 IQDIERHFZVCNRZ-LZOOXBQUSA-N 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 241000334160 Isatis Species 0.000 description 1
- DTGKSKDOIYIVQL-MRTMQBJTSA-N Isoborneol Natural products C1C[C@@]2(C)[C@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-MRTMQBJTSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241001502129 Mullus Species 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- PSZDOEIIIJFCFE-UHFFFAOYSA-N Oleanolic alcohol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(CO)CCC(C)(C)CC5C4=CCC3C21C PSZDOEIIIJFCFE-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 208000007027 Oral Candidiasis Diseases 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 244000021150 Orbignya martiana Species 0.000 description 1
- 235000014643 Orbignya martiana Nutrition 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000218641 Pinaceae Species 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 244000179560 Prunella vulgaris Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000282806 Rhinoceros Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241001441745 Sepia esculenta Species 0.000 description 1
- IQDIERHFZVCNRZ-LRCDAWNTSA-N Sipeimine Chemical compound C([C@@H]1C(=O)C[C@H]2[C@@H]3CC[C@H]4[C@]5(C)O)[C@@H](O)CC[C@]1(C)[C@H]2C[C@H]3[C@@H]4CN1[C@H]5CC[C@H](C)C1 IQDIERHFZVCNRZ-LRCDAWNTSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 241000257673 Strobilanthes cusia Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 241000287411 Turdidae Species 0.000 description 1
- 241000217379 Unionidae Species 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000003797 alkaloid derivatives Chemical group 0.000 description 1
- FAMPSKZZVDUYOS-UHFFFAOYSA-N alpha-Caryophyllene Natural products CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 229910052925 anhydrite Inorganic materials 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- JXSVIVRDWWRQRT-UYDOISQJSA-N asiatic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C JXSVIVRDWWRQRT-UYDOISQJSA-N 0.000 description 1
- 229940011658 asiatic acid Drugs 0.000 description 1
- LBGFKBYMNRAMFC-PYSQTNCISA-N asiatic acid Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@]2(C)[C@H]1C)C(=O)O LBGFKBYMNRAMFC-PYSQTNCISA-N 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- QBUVFDKTZJNUPP-UHFFFAOYSA-N biliverdin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(C=C3C(=C(C=C)C(=O)N3)C)=N2)CCC(O)=O)N1 QBUVFDKTZJNUPP-UHFFFAOYSA-N 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 208000010217 blepharitis Diseases 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000010238 camphora Substances 0.000 description 1
- 229940025250 camphora Drugs 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 229910001748 carbonate mineral Inorganic materials 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940117948 caryophyllene Drugs 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 125000000567 diterpene group Chemical group 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 201000010582 ecthyma Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000001827 electrotherapy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- PSZDOEIIIJFCFE-OSQDELBUSA-N erythrodiol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(CO)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C PSZDOEIIIJFCFE-OSQDELBUSA-N 0.000 description 1
- HTZRWCSRPTWJCT-UHFFFAOYSA-N erythrodiol Natural products CC1(C)CCC2(CO)CCC3C(CCC4C3(C)CCC5C(C)(C)C(O)CCC45C)C2C1 HTZRWCSRPTWJCT-UHFFFAOYSA-N 0.000 description 1
- CLXOLTFMHAXJST-UHFFFAOYSA-N esculentic acid Natural products C12CC=C3C4CC(C)(C(O)=O)CCC4(C(O)=O)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(CO)C CLXOLTFMHAXJST-UHFFFAOYSA-N 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000000630 fibrocyte Anatomy 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000000971 hippocampal effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- HIDAYMRWVVNXAO-UHFFFAOYSA-N imperialone Natural products CC1(O)C2CCC3C4CC(=O)C5CC(=O)CCC5(C)C4CC3C2CN2C1CCC(C)C2 HIDAYMRWVVNXAO-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000011667 zinc carbonate Substances 0.000 description 1
- 235000004416 zinc carbonate Nutrition 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention discloses a traditional Chinese medicine ointment for promoting wound healing after hemorrhoids and fistula operations and a preparation method thereof. The traditional Chinese medicine ointment is prepared by reasonably proportioning and scientifically processing keel, calamine, calcined gypsum, succinum, cuttlefish bone, stir-fried fankincense, prepared myrrh, calamitas urinae hominis, tendrilleaf fritillary bulb, pearl, natural indigo, calculus bovis, artificial bezoar, calomelas, dragon blood and borneol. The traditional Chinese medicine ointment for promoting wound healing after hemorrhoids and fistula operations can be matched with operation radical treatment for use, and can quickly heal operation wound surfaces from the aspects of microcirculation improvement, wound surface venous return separation promotion, phagotrophy system start, foreign matter elimination, infection control, blood flow motive power improvement, thrombosis resistance, the increase of the effective concentration of partial growth factors on wound surfaces, the acceleration of collagenous fiber synthesis and cell proliferation at wound surface points, the acceleration of recombination of collagenous fiber and cells on wound surfaces, etc. The ointment has significant application effect, and can be broadly used for patients after hemorrhoids and fistula operations.
Description
Technical field
The invention belongs to a kind of Chinese medicine unguentum, particularly a kind of Chinese medicine unguentum that promotes wound healing after anal fistula operation and preparation method thereof.
Background technology
Hemorrhoid complicated by anal fistula is a kind of commonly encountered diseases that influences human health, and sickness rate is high, and in normal population, total incidence accounts for 87%, and its source of disease is many because of liver, stomach damp invasion of lower energizer, causes the large intestine anal regions that noxious dampness foul smell is arranged, formation focus of a specified duration.The influence of the external pressure when being stressed during constipation or sitting quietly for a long time can further worsen or split, and causes hemorrhagely, even causes to infect and develops complications exacerbated.Treatment for hemorrhoid complicated by anal fistula has several different methods, as operation, washout, clothes for oral administration, outer, electrotherapy etc.Take western medicine, general curative effect is slower, can not effect a radical cure; The general curative effect of operative treatment is very fast, but all there is the tendency of certain delayed healing and disunion in postoperative wound surface.Adopt at present the prescription of traditional Chinese medicine composition for treating also more, if any be the Chinese medicine of main component preparation with Moschus, Semen Strychni, this kind Chinese medicine all can not be taken hyperpietic and anemia of pregnant woman; What also have is primary raw material with Radix Arnebiae (Radix Lithospermi), Cortex Phellodendri, Radix Scutellariae, Rhizoma Polygoni Cuspidati, Radix Glycyrrhizae, Radix Sanguisorbae, Borneolum Syntheticum, makes ointment, and perfusion is used to affected area, though this medicine has curative effect preferably, can not combine with operative treatment, is used for wound healing promoting, therefore, cures still slower.
Summary of the invention
The object of the present invention is to provide a kind of can combining with operative treatment, and can infection, consumer edema, the sepage of minimizing wound tissue, promote wound healing, not only have the fast effect of curative effect, but also have the Chinese medicine unguentum of the promotion wound healing after anal fistula operation of radical cure effect.
Another object of the present invention is to provide a kind of preparation method of Chinese medicine unguentum of aforesaid promotion wound healing after anal fistula operation.
For reaching above purpose; the technical solution adopted in the present invention is: the Chinese medicine unguentum of this promotion wound healing after anal fistula operation; it is characterized in that it is made by the following weight parts Chinese medicinal raw materials: Os Draconis 220-260g; Calamina 90-110g, Gypsum Fibrosum Preparatum 110-134g, succinum 20-40g; Endoconcha Sepiae 110-136g; Olibanum (processed) 30-60g, Myrrha (processed) 30-60g, calamitas urinae hominis 60-80g; Bulbus Fritillariae Cirrhosae 20-30g; Margarita 2-6g, Indigo Naturalis 70-80g, Calculus Bovis 2-6g; artificial Calculus Bovis 6-10g; Calomelas 38-60g, Sanguis Draxonis 40-60g, Borneolum Syntheticum 9-11g.
This promotes the Chinese medicine unguentum of wound healing after anal fistula operation, and the weight portion proportioning of its raw material of Chinese medicine is: Os Draconis 243g, Calamina 97g; Gypsum Fibrosum Preparatum 121g, succinum 29g, Endoconcha Sepiae 122g; Olibanum (processed) 48g, Myrrha (processed) 48g, calamitas urinae hominis 73g; Bulbus Fritillariae Cirrhosae 24g, Margarita 4g, Indigo Naturalis 73g; Calculus Bovis 4g, artificial Calculus Bovis 8g, Calomelas 48g; Sanguis Draxonis 48g, Borneolum Syntheticum 10g.
The preparation method of the Chinese medicine unguentum of aforesaid promotion wound healing after anal fistula operation, its production stage is:
(1), earlier with Os Draconis, Calamina, Gypsum Fibrosum, Margarita, Olibanum, Myrrha respectively by 2002 version " Shandong Province's Chinese medicine processing standard " concoct;
(2), in above cooperation ratio weighing Os Draconis 220-260g, Calamina 90-110g, Gypsum Fibrosum Preparatum 110-140g, succinum 20-40g, Endoconcha Sepiae 110-136g, Olibanum (processed) 30-60g, Myrrha (processed) 30-60g, calamitas urinae hominis 60-80g, Bulbus Fritillariae Cirrhosae 20-30g, Margarita 2-6g, Indigo Naturalis 70-80g, Calculus Bovis 2-6g, artificial Calculus Bovis 6-10g, Calomelas 38-60g, Sanguis Draxonis 40-60g, Borneolum Syntheticum 9-11g, and divide into groups, with Os Draconis, Calamina, Gypsum Fibrosum Preparatum, succinum, Endoconcha Sepiae, Olibanum (processed), Myrrha (processed), the calamitas urinae hominis, Bulbus Fritillariae Cirrhosae, Margarita is as first group of medicine, with Indigo Naturalis, Calculus Bovis, the artificial Calculus Bovis is standby as second group of medicine, with Calomelas, Sanguis Draxonis, the independent weighing of Borneolum Syntheticum is good standby as the 3rd group of medicine;
(3), earlier load weighted first group of medicine dried, pulverizes, crosses the 100-120 mesh sieve, is mixed into first group of medicament mixed powder; Load weighted second group of medicine by the ground and mixed method, put in the mortar, mixed while grinding, cross the 100-120 mesh sieve, mixing becomes second group of medicament mixed powder; Adopt the bottoming chromatography to mix earlier to first group of medicament mixed powder and second group of medicament mixed powder, adopt the equivalent incremental method to mix again, till first group of medicament mixed powder added, after the 100-120 mesh sieve, mixing was repeatedly won, two groups of medicament mixed powder; Calomelas, Sanguis Draxonis, Borneolum Syntheticum list ground 100 mesh sieves, became the 3rd group of medicine powder, because of the 3rd group of medicine is volatile medicine, so single bag is standby;
(4), take by weighing white vaseline 8000g, lanoline 1000g, dimethyl sulfoxide 10g, as substrate, substrate is put in the evaporating dish, heating in water bath dissolves, in the time of in keeping 65-75 ℃ of scope of temperature, constantly stir on one side, produce more than slowly adding on one side first, two groups of medicament mixed powder, when temperature rises to 100 ℃, kept 15-20 minute, stop the heating cooling, when temperature is reduced to 30 ℃-40 ℃, again with the Calomelas in volatile the 3rd group of medicine powder, Sanguis Draxonis powder, Borneolum Syntheticum powder slowly adds respectively, stirring to make this Chinese medicine unguentum, but last packing.
The pharmacology of this Chinese medicine unguentum is:
Os Draconis are the skeleton fossil of mammals in ancient times (as Hippocampal cortex, rhinoceros class, deer class, bovine, resemble class etc.).Remove silt impurity, store in dry place, the time spent smashes, give birth to or forge usefulness.Meridian distribution of property and flavor, sweet, puckery, be slightly cold GUIXIN, Liver Channel.Have suppressing the hyperactive liver and subsiding YANG, tranquillizing and allaying excitement, the astringent or styptic treatment for spontaneous sweating effect of convergence, forge Os Draconis and grind external into powder, have moisture absorption to hold back the skin ulcer effect.
Calamina is a carbonate mineral calcite family smithsonite, the main zinc carbonate (ZnCo that contains
3).Excavate afterwash, dry, remove roguing stone.This medicine body is light, frangible, feeble QI, and it is little puckery to distinguish the flavor of.Nature and flavor with return through: sweet, put down, return the stomach warp.Has the detoxifcation improving acuity of vision and removing nebula, the antipruritic effect of holding back skin ulcer of removing dampness.Be used for that conjunctival congestion and swelling pain, marginal blepharitis, nebula film bulbar conjunctiva polyp, ulcer being unable to heal, dense water are dripping, eczema, skin pruritus.Other has data to show: Calamina has certain bacteriostasis, and health tissues and newborn epithelial tissue are had protective effect, can make the inflammation limitation after the medication very soon; and can impel the granulation of outstanding wound surface and slough to liquefy; make the wound surface cleaning smooth, be easy to repair, receive the effect that rotten flesh is to the greatest extent given birth to.Calamina in this Chinese medicine unguentum has the convergence secretion inhibitor or partially absorbs the effect of wound surface juice, minimizing suppuration, protection wound surface.
Gypsum Fibrosum Preparatum is a Sulfates mineral anhydrite family Gypsum Fibrosum, main hydrous calcium sulfate (CaSo
42H2.), after excavating, remove silt and assorted stone.This medicine is sweet, hot, Great Cold, attach to the lung and stomach meridians.Has the effect that clearing away heat-fire, relieving restlessness quench the thirst.Be mainly used in fever caused by exogenous pathogenic factors, hyperpyrexia excessive thirst, dyspnea and cough due to lung-heat, stomach a heatable brick bed Sheng, headache toothache.Gypsum Fibrosum Preparatum can be restrained mucosa and be reduced secretion, is used for skin infection and festers and do not hold back, and eczema is invaded excessive and burn due to hot liquid or fire etc.
Succinum for ancient times pinaceae plant bury in underground the fossil sample material that condenses for a long time year in year out and be transformed.Sweet, flat, GUIXIN, liver, urinary bladder channel.Effect with tranquillizing the mind by relieving convulsion, blood circulation promoting and blood stasis dispelling.Be mainly used in malaise, infantile convulsion, demented, epilepsy, stranguria with blood, stranguria caused by urinary stone pyretic stranguria.Especially be suitable for illness such as the treatment skin ulcer swells and ache bitterly, scrofula disease, goiter, incised wound wound.
Endoconcha Sepiae is the then dry inner shell of section animal sepiella maindroni de Rochebrune sepiella maind roni deRochebrune or golden cuttlefish sepia esculenta Hoyle of mullet.One-tenth, puckery, warm.Return spleen, kidney channel.Has the effect that astringing to arrest bleeding, relieving leukorrhea by astringents, antacid are held back skin ulcer.Be mainly used in Peptic Ulcers, hyperchlorhydria, hematemesis and epistaxis, the metrorrhagia seminal emission acid regurgitation of having blood in stool, have a stomachache of having blood in stool; The external treatment bleeding due to trauma, the many pus of skin ulcer.Heal, change gastric content pH value, reduction pepsin activity, promotion union of fracture, shortening healing time, promotion fibrocyte and osteoblast hypertrophy and ossify with gastric acid, promotion ulcer surface in the energy.
Olibanum (processed) be Burseraceae dungarunga Boswellia carterii Birdw and belong to together, resin system that plant skin zone oozes out uses.Hot, bitter, warm.Return liver, the heart, spleen channel.Effect with promoting blood circulation and stopping pain, lock pain, detumescence and promoting granulation.Be usually used under all pains of stagnation of blood stasis (as trusted subordinate's stasis of blood pain, dysmenorrhea and traumatic injury, diseases such as carbuncle pain and rheumatic arthralgia), skin infection is not regained after bursting for a long time, can promote multinuclear leucocyte to increase behind the oral Olibanum (processed), to engulf dead hemocyte, improve metabolism, thereby antiinflammation is arranged, and can be used to anticorrosion and the elimination halitosis, quicken inflammation and ooze out drainage, absorption, promote wound healing.
Myrrha (processed) be Burseraceae shrub or arbor not loblolly tree or other congener skin zones oleo-gum-resin system of oozing out use.This medicine suffering, hardship, flat.GUIXIN, liver, spleen channel.Effect with promoting blood circulation and stopping pain, detumescence and promoting granulation.Be mainly used in control traumatic injury be retarded by silt swell and ache, surgery carbuncle and painful swelling, skin infection do not close up after bursting for a long time, and all pains of all stasis trusted subordinates.Pharmacological evaluation shows, various pathogens is had in various degree inhibitory action; And prevent that speckle from forming.
The calamitas urinae hominis: salty, flat, nontoxic, can removing fire from the liver, three warmers fight bladder fire, pathogenic fire reducing, main effect is that disappear congestion, heat-clearing and toxic substances removing, erosion prevention and muscle growing, hemostasis is treated aphtha, throat, ability to speak and given birth to skin ulcer, cures mainly thrush, suppurative tonsillitis, oral ulcer etc.
Bulbus Fritillariae Cirrhosae is liliaceous plant Bulbus Fritillariae Cirrhosae Fritiuaria cirrhosa D.Don, dark violet Bulbus Fritillariae Uninbracteatae Fritillaria unibrac teataHsiao etk, c.Hsia, Gansu Bulbus Fritillariae Uninbracteatae FritillariaPrzewalskii Maxim, or the dry squama base of Bulbus Fritillariae cirrhosae Fritillaria delavayi Fianch.Former three is practised title " loose shellfish " and " blue or green shellfish " respectively by the character difference, and the latter practises title " lubei ".Adopt control when summer, Qiu Erji or snow melting, remove fibrous root, rough bark and silt dry or cold drying.This medicine hardship, sweet, be slightly cold.Return lung, heart channel.Effect with clearing heat and moistening lung, preventing phlegm from forming and stopping coughing.Be mainly used in lung-heat type cough, the few expectorant of dry cough, deficiency of YIN chronic cough, sputum with blood.Bulbus Fritillariae Cirrhosae fluidextract, fritimine all have phlegm-dispelling functions in various degree; Bulbus Fritillariae Uninbracteatae total alkali and non-alkaloid part all have antitussive effect; The Bulbus Fritillariae Uninbracteatae total alkali still has antiulcer action.Fritimine has hypotensive effect; Imperialine also can spasmolytic; Experiment in vitro shows that Bulbus Fritillariae Cirrhosae has the effect that suppresses escherichia coli and Staphylococcus aureus.
Margarita is the Margarita that pearl shell animal Pteria martensii Dunker Pteria martensii (Dunker) Unionidae animal hydriopsis cumingii Hyriopsis cumingii (lea) or cristaria plicata Cristaria plicata bivalve irriates such as (leach) form.In animal body, take out cleaning, drying.This medicine is sweet, salty, cold.GUIXIN, Liver Channel.Effect with the arresting convulsion of calming the nerves, the removing nebula that makes eye bright, removing toxic substances and promoting granulation is mainly used in palpitation with fear insomnia, infantile convulsion epilepsy, order life nebula, skin infection is not held back.Had a guilty conscience heat, then manner is floating more; High heat-phlegm fan, the then frightened fault of mind; Deficiency of the liver has heat, and then order is given birth to cataracta.The heat of separating two warps is promptly arranged, can grow the moon of two warps again, and tranquilizing by nourishing the heart is arranged, the merit of relieving convulsion bob expectorant, the removing nebula that makes eye bright is so the disease two of deficiency of YIN excess of YIN gets its usefulness.Be used for the swollen ulcer drug ulcer being unable to heal, the energy removing toxic substances and promoting granulation that applies closes up.Oral administration and externally is attacked to imitate and is developed simultaneously.
Indigo Naturalis is dried powder or the agglomerate that the base of leaf leaf of acanthaceous vegetable acanthaceous indigo Baphica canthus cusia (Nees) Bremek. polygonaceae plant polygonum tinctorium ait. Polygonum tinctorium Ai or cruciferae isatis Isatisind igoticg Fort gets through value processing.This medicine is navy blue powder, and body gently, easily fly upward; Or be irregular porous agglomerate, with hand rubbing twist with the fingers smalls.Little have careless fishy smell, lightly seasoned.Salty, tremble with fear, return Liver Channel.Effect with heat-clearing and toxic substances removing, removing heat from blood arresting convulsion.Be mainly used in that noxious dampness is sent out speckle, heat in blood is told nosebleed, chest pain hemoptysis, skin ulcer, mumps, sore throat, pediatric epilepsy scared; Be usually used in eczema, eczema, dispute throat ulcer again.Other have data show the immersion of Indigo Naturalis ethanol external to anthrax bacillus, pneumobacillus, dysentery bacterium, comma bacillus, gold-coloured staphylococci and Staphylococcus albus etc., inhibitory action is all arranged.
Calculus Bovis is the exsiccant cholelithiasis of bovid cattle Bog tqurus domesticus Gmelin, when slaughtering an ox, as finding that Calculus Bovis is arranged, being elimination bile, with middle yellow the taking-up, removes outside thin film, dries in the shade.This medicine is sweet, cool.GUIXIN, Liver Channel.Have clear away heart-fire, eliminating phlegm, have one's ideas straightened out, the effect of cool liver, endogenous wind stopping, detoxifcation.Be mainly used in calentura coma, middle wind-phlegm fan, frightenedly not busyly twitch, epilepsy is gone mad, laryngopharynx swelling and pain, aphtha of the mouth and tongue, carbuncle furuncle.This medicine contains bile acid, cholochrome, bilirubin, cholesterol, biliverdin, vitamin D and several amino acids; Also contain sodium, calcium, magnesium, ferrum, copper, phosphorus and carotene and mucin, fatty acid and peptide constituents.There is the artificial Calculus Bovis the present, is to extract processing and manufacturing and form through artificial from Fel Bovis seu Bubali or Fel Sus domestica, and its performance, effect are similar to natural Calculus Bovis, and are widely adopted, but the too late natural Calculus Bovis of power; Be used for pyretic toxicity diseases such as laryngopharynx swelling and pain, carbuncle sore tumefacting virus more.Epidemic febrile disease, hyperpyrexia, coma, tiqueur still are advisable with natural Calculus Bovis.
Calomelas is white glossiness flakey or flakes crystalline powder.Odorless, almost tasteless, meet slowly deepening of light color.Hot, cold, poisonous, return large intestine, small intestine meridian.But external parasite killing, counteracting toxic substances, hold back skin ulcer; The removing food stagnancy that can eliminate the phlegm for oral administration, the outer is used for scabies, stubborn dermatitis, ecthyma, syphilis, skin infection, eczema, so be suitable for pruritus especially, create infections and festers, dermatosis such as have an itch that pus is dripping.
Sanguis Draxonis is that the resin that oozes out of babassu Sanguis Draxonis Daemonor ops draco Bl fruit is through being processed into.Levigation is brick-red, feeble QI, lightly seasoned, and is insoluble in water, softening in hot water.Nature and flavor with return through: sweet, salty, flat, GUIXIN, Liver Channel.Effect with removing blood stasis and relieving pain, hemopoietic granulation promoting.1. be used for traumatic hemorrhage, ulcer being unable to heal, external has hemostasia and promoting granulation to hold back the effect of skin ulcer.2. be used for traumatic injury, swelling and pain due to blood stasis, the eliminating stasis to stop pain effect is arranged.
Borneolum Syntheticum is the processed goods of Dipterocarpaceae plant Borneolum Syntheticum resin, or the trunk of Borneolum Syntheticum claims " borneol " through distilling the crystallization of cooling off and getting.This medicine suffering, hardship, be slightly cold.GUIXIN, spleen, lung meridian have the effect of the refreshment of having one's ideas straightened out, clearing away heat to alleviate pain.Be mainly used in that calentura coma, convulsion are fainted, apoplexy syncope due to accumulation of phlegm, stagnation of QI sudden syncope, attacked by pestiferous factors stupor, conjunctival congestion, aphtha, laryngopharynx swelling and pain, auditory meatus is suppurated.Contain in the borneol and revolve Borneolum Syntheticum, Diterpenes composition such as doubly rich ter penoids such as Humuleno, B one elemene, caryophyllene and oleanolic acid, alphitolic acid, asiatic acid, dryobalanone, erythrodiol.Synthetic borneol mainly contains Borneolum Syntheticum, isoborneol, Camphora etc.Natural Broneolum Syntheticum and synthetic borneol all have bacteriostasis, and have the division and the growth that promote neurogliocyte to use; Sensory nerve there is slight stimulation and pain relieving; Gentle antisepsis is still arranged.Experiment in vitro has the hog cholera of inhibition bacterium, escherichia coli, the effect of staphylococcus aureus growth.This medicine has putrefaction-removing granulation-promoting, easing pain and diminishing inflammation, bactericidal haemostatic, putrefaction removing and holds back the skin ulcer effect, is applicable to ulcer or the postoperative wound surface person of not holding back.
Sanguis Draxonis in this Chinese medicine unguentum side and blood close up, Olibanum (processed), Myrrha (processed) promoting blood circulation and stopping pain, and detumescence and promoting granulation, Os Draconis granulation promoting removing dampness, Calomelas are longer than and are attacked sore, and removing dampness is held back skin ulcer, killing parasites for relieving itching, Gypsum Fibrosum Preparatum convergence mucosa reduces secretion.The Endoconcha Sepiae astringing to arrest bleeding is held back the skin ulcer evacuation of pus.Indigo Naturalis, Calculus Bovis, Margarita, Borneolum Syntheticum are with having heat-clearing and toxic substances removing, the merit of mass dissipating and swelling eliminating.All medicines share, and have heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, dissipate with short, the heat clearing away poison holding, to promote the evacuation of pus of skin infection ulceration, putrefaction removing is held back skin ulcer, the effect of granulation promoting.
The Chinese medicine unguentum that adopts this promotion wound healing after anal fistula operation did on one's body that xylol causes that mice auricle swelling influence, on Carrageenan cause rat toes swelling influence and to the test of mice hot plate analgesia influence mice, and the Chinese medicine unguentum xylol that proves this promotion wound healing after anal fistula operation causes mice auricle swelling the obvious suppression effect; The rat toes rate that swells and ache obviously reduces; The stomachache that Dichlorodiphenyl Acetate causes has the obvious suppression effect, and the mouse writhing number of times obviously reduces, and in the test, does not find that wound surface has stimulation, does not see that anaphylaxis takes place.In bacteriostatic test, by resistant activity test to 7 strains, 123 strain bacterium, the sensitivity of having observed antimicrobial spectrum, bacterial strain distributes, minimal inhibitory concentration, the result shows: this promotes that the Chinese medicine unguentum antimicrobial spectrum of hemorrhoid complicated by anal fistula art wound healing is more extensive, staphylococcus aureus, staphylococcus epidermidis, bacillus subtilis, bacillus pyocyaneus, Fructus Lycii acidfast bacilli, Bacillus proteus, Salmonella, escherichia coli, dysentery bacterium, enterococcus there are inhibitory action in various degree, especially staphylococcus aureus are suppressed obviously.
The using method of the Chinese medicine unguentum of this promotion wound healing after anal fistula operation is: at first to the hemorrhoid complicated by anal fistula treatment that undergos surgery, second day after operation greatly after an action of the bowels, earlier with after the demibain of compound recipe cyanines mustard fumigation and washing agent, reuse should promote the Chinese medicine unguentum external application surgical wound surface of wound healing after anal fistula operation, press the external application of wound surface size, till applying full whole wound surface, the gauze wrapping, immobilization with adhesive tape, once, do not defecate after defecating in general one day, change once after demibain every day yet, one day 2 times stool is changed 2 times, changes dressings at last to surgical wound surface and all heals.
Adopt Chinese medicine unguentum clinical treatment 166 examples of this promotion wound healing after anal fistula operation, wherein male 79 examples, women 87 examples; Age 12-70 year; The course of disease 1 thoughtful 30 years.Ring-shaped mixed hemorrhoids 20 examples, high anal fistula 30 examples, low level complexity anal fistula 50 examples, anal fissure companion connective tissue external hemorrhoid 26 examples, perianal abscess is once cut radical cure 40 examples.Other has 150 examples to compare, and its sex, age, the course of disease, sick kind and postoperative wound surface size have comparability with observation group.
Find out from the treatment comparing result: the treatment group natural law that on average heals is 15.2 days, on average heal natural law 21.0 days of matched group, wherein: ring-type is mixed Zhi 20 examples in the treatment group, healing time is 12~17 days, average out to 14 days, and 20 15~21 days routine ring-shaped mixed hemorrhoids wound healing times in the matched group, average 17 days, the treatment group on average healed 3 days in advance than matched group; High anal fistula 30 examples in the treatment group, healing time is 20~31 days, average out to 24 days, and high anal fistula 28 examples in the matched group, healing time is 25-40 days, average 32 days, the treatment group was than matched group healing in 8 days in advance; Low level complexity anal fistula 50 examples in the treatment group, healing time is 16~21 days, average 19 days, and matched group 48 examples, healing time is 18-23 days, average out to 22 days, and the treatment group shifts to an earlier date 3 days than matched group; Anal fissure in the treatment group is mixed connective tissue external hemorrhoid 26 examples, and healing time is 11~14 days, and average 12 days, and 20 routine healing times are 14-17 days in the matched group, average 16 days, the treatment group was than matched group healing in 4 days in advance; Perianal abscess in the treatment group is once cut radical cure 40 examples, and healing time is 12-42 days, and average 19 days, and 34 routine healing times in the matched group are 20~52 days, average 27 days, the treatment group on average shifted to an earlier date 8 days than matched group.
The continuous days comparison sheet in treatment group and matched group wound healing each stage of process
The wound healing evaluation criteria:
Wound healing is pressed four-stage: 1. blood coagulation, prevent that blood further runs off, and guarantee the mechanical strength at wound place; 2. inflammatory reaction is that wound separates with venous return, starts the system of engulfing and eliminates foreign body, control infection; 3. granulation tissue forms, and comprises the propagation of the synthetic and cell of collagen at the wound place; 4. reorganization comprises reconfiguring of collagen fiber and cell, to improve maximum mechanical strength.Any one link of this four-stage is affected, and all may prolong the wound healing time.
Beneficial effect of the present invention is: can be used with surgical radical treatment, and can from microcirculation improvement, promote the wound surface venous return separately, starting engulfs system, eliminates foreign body, control infection, improves hemodynamic, antithrombotic forms, increase the wound surface local growth factor valid density, quicken the synthetic and cell of collagen fiber in the propagation of wound surface, quicken aspect such as reconfiguring of wound surface collagen fiber and cell and start with, cause the surgical wound surface quickly-healing, effect is obvious.
Embodiment
Embodiment 1
Take by weighing raw material of Chinese medicine by following weight portion proportioning: Os Draconis 243g, Calamina 97g, Gypsum Fibrosum Preparatum 121g, succinum 29g, Endoconcha Sepiae 122g, Olibanum (processed) 48g; Myrrha (processed) 48g, calamitas urinae hominis 73g, Bulbus Fritillariae Cirrhosae 24g, Margarita 4g, Indigo Naturalis 73g; Calculus Bovis 4g, artificial Calculus Bovis 8g, Calomelas 48g, Sanguis Draxonis 48g, Borneolum Syntheticum 10g.
Load weighted above raw material of Chinese medicine is made the Chinese medicine unguentum that promotes the post-operative hemorrhoids and anal fistula healing by following production stage:
(1) at first with Os Draconis, Calamina, Gypsum Fibrosum, Margarita, Olibanum, Myrrha respectively by 2002 version " Shandong Province's Chinese medicine processing standard " concoct;
(2) with above load weighted Os Draconis, Calamina, Gypsum Fibrosum Preparatum, succinum, Endoconcha Sepiae, Olibanum (processed), Myrrha (processed), calamitas urinae hominis, Bulbus Fritillariae Cirrhosae, Margarita as first group of medicine, above load weighted Indigo Naturalis, Calculus Bovis, artificial Calculus Bovis is standby as second group of medicine, above load weighted Calomelas, Sanguis Draxonis, the independent weighing of Borneolum Syntheticum is good standby as the 3rd group of medicine;
(3), earlier load weighted first group of medicine dried, pulverizes, crosses 110 mesh sieves, is mixed into first group of medicament mixed powder; Load weighted second group of medicine by the ground and mixed method, put in the mortar, mixed while grinding, cross 110 mesh sieves, mixing becomes second group of medicament mixed powder; To first group of medicament mixed powder and second group of medicament mixed powder, adopt earlier the bottoming chromatography to mix, adopt the equivalent incremental method to mix again, till first group of medicament mixed powder added, after 100 mesh sieves, mixing was repeatedly won, two groups of medicament mixed powder; Calomelas, Sanguis Draxonis, Borneolum Syntheticum list ground 100 mesh sieves, were the 3rd group of medicine powder, and single bag is standby;
(4), take by weighing white vaseline 8000g, lanoline 1000g, dimethyl sulfoxide 10g, as substrate, substrate is put in the evaporating dish, heating in water bath dissolves, in the time of in keeping 70 ℃ of scopes of temperature, constantly stir on one side, produce more than slowly adding on one side first, two groups of medicament mixed powder, when temperature rises to 100 ℃, kept 20 minutes, stop the heating cooling, when temperature is reduced to 38 ℃, again with the Calomelas in volatile the 3rd group of medicine powder, Sanguis Draxonis powder, Borneolum Syntheticum powder slowly adds respectively, stirring to make the Chinese medicine unguentum that promotes wound healing after anal fistula operation, but last packing.
Model case
Patient Yang Guidong, the man, 36 years old, admission number 10491 because of in the swollen thing distending pain companion of the anus anus swollen thing being arranged, needed hand rest to show effect repeatedly 10 years from anal prolapse, increases the weight of 2 years.In income hemorrhoid department ward on March 30th, 2004, the back diagnosis of being admitted to hospital; The ring-shaped mixed hemorrhoids III phase, outside epidural anesthesia is descending, prick art in the stripping, postoperative is changed dressings 2 times every day, after the sterilization of povidone iodine cotton balls, wound surface is crowded with Chinese medicine unguentum of this promotion post-operative hemorrhoids and anal fistula healing, the gauze wrapping, immobilization with adhesive tape, wound surface is healed entirely behind the first quarter moon altogether, does not see other side effect.Treat similar case totally 12 examples with this prescription, all in 12-16 days, heal, do not see other side effect.
Embodiment 2
Take by weighing raw material of Chinese medicine by following weight portion proportioning: Os Draconis 220g, Calamina 106g, Gypsum Fibrosum Preparatum 130g, succinum 38g, Endoconcha Sepiae 110g, Olibanum (processed) 30g; Myrrha (processed) 40g, calamitas urinae hominis 75g, Bulbus Fritillariae Cirrhosae 28g, Margarita 5g, Indigo Naturalis 78g; Calculus Bovis 5g, artificial Calculus Bovis 7g, Calomelas 60g, Sanguis Draxonis 58g, Borneolum Syntheticum 10g.Its production stage such as embodiment 1, but all adopt 100 mesh sieves after pulverizing.
Model case
Patient Han Yingzhang, man, 26 years old, admission number: 26690, because of 3 pus mouths, the swelling water of suppurating is arranged around the anus, showed effect repeatedly 5 years, increased the weight of 10 days, in income hemorrhoid complicated by anal fistula ward on August 12nd, 2005, AD: low level complexity anal fistula, at the descending segmentation of the epidural anesthesia drain hanging wire postoperative of windowing, change dressings once a day, with after the sterilization of povidone iodine cotton balls, wound surface is crowded with this Chinese medicine unguentum when changing dressings, the gauze wrapping, immobilization with adhesive tape 28 days, wound surface is healed entirely, does not see other side effect.Have 17 examples with the similar case of this prescription treatment, all in 17-21 days, heal, do not see other side effect.
Embodiment 3
Take by weighing raw material of Chinese medicine by following weight portion proportioning: Os Draconis 260g, Calamina 90g, Gypsum Fibrosum Preparatum 110g, succinum 28g, Endoconcha Sepiae 110g, Olibanum (processed) 30g; Myrrha (processed) 35g, calamitas urinae hominis 80g, Bulbus Fritillariae Cirrhosae 30g, Margarita 5g, Indigo Naturalis 80g; Calculus Bovis 5g, artificial Calculus Bovis 7g, Calomelas 60g, Sanguis Draxonis 60g, Borneolum Syntheticum 10g.Its production stage such as embodiment 1, but all adopt 100 mesh sieves after pulverizing.
Model case
Patient QiMin, woman, 24 years old, admission number 24130, in income hemorrhoid department ward on May 13rd, 2005, be diagnosed as anal fissure companion connective tissue external hemorrhoid, after the underwent operative treatment, change dressings every day 2 times, after the sterilization of povidone iodine cotton balls, wound surface is crowded with Chinese medicine unguentum of this promotion post-operative hemorrhoids and anal fistula healing, the gauze wrapping, immobilization with adhesive tape after 13 days wound surface heal entirely, do not see other side effect.Treat similar case totally 10 examples with this prescription, other side effect are not seen in all healings in 11~14 days.
Claims (3)
1. Chinese medicine unguentum that promotes wound healing after anal fistula operation is characterized in that it is made by the following weight parts Chinese medicinal raw materials: Os Draconis 220-260g, Calamina 90-110g; Gypsum Fibrosum Preparatum 110-134g, succinum 20-40g, Endoconcha Sepiae 110-136g; Olibanum (processed) 30-60g, Myrrha (processed) 30-60g, calamitas urinae hominis 60-80g; Bulbus Fritillariae Cirrhosae 20-30g, Margarita 2-6g, Indigo Naturalis 70-80g; Calculus Bovis 2-6g, artificial Calculus Bovis 6-10g, Calomelas 38-60g; Sanguis Draxonis 40-60g, Borneolum Syntheticum 9-11g.
2. the Chinese medicine unguentum of promotion wound healing after anal fistula operation according to claim 1 is characterized in that its raw material of Chinese medicine weight portion proportioning is: Os Draconis 243g, Calamina 97g; Gypsum Fibrosum Preparatum 121g, succinum 29g, Endoconcha Sepiae 122g; Olibanum (processed) 48g, Myrrha (processed) 48g, calamitas urinae hominis 73g; Bulbus Fritillariae Cirrhosae 24g, Margarita 4g, Indigo Naturalis 73g; Calculus Bovis 4g, artificial Calculus Bovis 8g, Calomelas 48g; Sanguis Draxonis 48g, Borneolum Syntheticum 10g.
3. the preparation method of the Chinese medicine unguentum of promotion wound healing after anal fistula operation as claimed in claim 1 is characterized in that its production stage is:
(1), earlier with Os Draconis, Calamina, Gypsum Fibrosum, Margarita, Olibanum, Myrrha respectively by 2002 version " Shandong Province's Chinese medicine processing standard " concoct;
(2), in above cooperation ratio weighing Os Draconis 220-260g, Calamina 90-110g, Gypsum Fibrosum Preparatum 110-140g, succinum 20-40g, Endoconcha Sepiae 110-136g, Olibanum (processed) 30-60g, Myrrha (processed) 30-60g, calamitas urinae hominis 60-80g, Bulbus Fritillariae Cirrhosae 20-30g, Margarita 2-6g, Indigo Naturalis 70-80g, Calculus Bovis 2-6g, artificial Calculus Bovis 6-10g, Calomelas 38-60g, Sanguis Draxonis 40-60g, Borneolum Syntheticum 9-11g, and divide into groups, with Os Draconis, Calamina, Gypsum Fibrosum Preparatum, succinum, Endoconcha Sepiae, Olibanum (processed), Myrrha (processed), the calamitas urinae hominis, Bulbus Fritillariae Cirrhosae, Margarita is as first group of medicine, with Indigo Naturalis, Calculus Bovis, the artificial Calculus Bovis is standby as second group of medicine, with Calomelas, Sanguis Draxonis, the independent weighing of Borneolum Syntheticum is good standby as the 3rd group of medicine;
(3), earlier load weighted first group of medicine dried, pulverizes, crosses the 100-120 mesh sieve, is mixed into first group of medicament mixed powder; Load weighted second group of medicine by the ground and mixed method, put in the mortar, mixed while grinding, cross the 100-120 mesh sieve, mixing becomes second group of medicament mixed powder; To first group of medicament mixed powder and second group of medicament mixed powder, adopt earlier the bottoming chromatography to mix, adopt the equivalent incremental method to mix again, till first group of medicament mixed powder added, after the 100-120 mesh sieve, mixing was repeatedly won, two groups of medicament mixed powder; Calomelas, Sanguis Draxonis, Borneolum Syntheticum list ground 100 mesh sieves, became the 3rd group of medicine powder;
(4), take by weighing white vaseline 8000g, lanoline 1000g, dimethyl sulfoxide 10g, as substrate, with substrate put in the evaporating dish, heating in water bath dissolves, in the time of in keeping 65-75 ℃ of scope of temperature, constantly stir on one side, first and second group medicament mixed powder of producing more than slowly adding on one side, when temperature rises to 100 ℃, kept 15-20 minute, stop the heating cooling, when temperature is reduced to 30 ℃-40 ℃, again Calomelas, Sanguis Draxonis powder, Borneolum Syntheticum powder in volatile the 3rd group of medicine powder are slowly added respectively, stirring to make this Chinese medicine unguentum, but last packing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100438187A CN100402074C (en) | 2006-04-19 | 2006-04-19 | A Chinese medicinal ointment for promoting wound healing after anal fistula operation and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100438187A CN100402074C (en) | 2006-04-19 | 2006-04-19 | A Chinese medicinal ointment for promoting wound healing after anal fistula operation and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1876085A CN1876085A (en) | 2006-12-13 |
CN100402074C true CN100402074C (en) | 2008-07-16 |
Family
ID=37508754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100438187A Expired - Fee Related CN100402074C (en) | 2006-04-19 | 2006-04-19 | A Chinese medicinal ointment for promoting wound healing after anal fistula operation and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100402074C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103961690A (en) * | 2014-05-25 | 2014-08-06 | 张勇 | External ointment for treating bedsore and preparation method thereof |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102068577B (en) * | 2011-01-05 | 2012-09-26 | 王广志 | Traditional Chinese medicine (TCM) composition and application thereof |
CN102198205B (en) * | 2011-04-28 | 2012-10-10 | 上海市金山区中心医院枫泾分院 | Lianzhi powder and preparation method thereof |
CN105687846A (en) * | 2016-03-11 | 2016-06-22 | 张雪燕 | Medicine composition for treating postoperative complications of hemorrhoids and fistula and application of medicine composition |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1183950C (en) * | 2003-04-16 | 2005-01-12 | 吉林敖东延边药业股份有限公司 | Chinese herbal medicine preparation for treating burns |
CN1615969A (en) * | 2004-09-15 | 2005-05-18 | 史敬杰 | Chinese medicine preparation pus drawing out plaster for treating pasteur cystic, furuncle, furunculosis and carbuncle |
-
2006
- 2006-04-19 CN CNB2006100438187A patent/CN100402074C/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1183950C (en) * | 2003-04-16 | 2005-01-12 | 吉林敖东延边药业股份有限公司 | Chinese herbal medicine preparation for treating burns |
CN1615969A (en) * | 2004-09-15 | 2005-05-18 | 史敬杰 | Chinese medicine preparation pus drawing out plaster for treating pasteur cystic, furuncle, furunculosis and carbuncle |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103961690A (en) * | 2014-05-25 | 2014-08-06 | 张勇 | External ointment for treating bedsore and preparation method thereof |
CN103961690B (en) * | 2014-05-25 | 2016-01-20 | 张勇 | A kind of external-applied ointment and preparation method for the treatment of decubital ulcer |
Also Published As
Publication number | Publication date |
---|---|
CN1876085A (en) | 2006-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101049466B (en) | Ointment of Chinese herbal medicine for treating burn and scald without pain, and scar, and preparation method | |
CN100402074C (en) | A Chinese medicinal ointment for promoting wound healing after anal fistula operation and preparation method thereof | |
CN106474245A (en) | A kind of Chinese medicine for treating epidermolysis bollosa | |
CN101249186A (en) | A traditional Chinese medicine oil preparation for treating trauma, rheumatic pain and toothache and its production method | |
CN105168091A (en) | Telangiectasis removing mask powder and preparation method thereof | |
CN105343271A (en) | Medicine for treating beriberi and preparation method of medicine | |
WO2022097105A1 (en) | Burn ointment using herbal compounds to repair a variety of infectious wounds | |
CN109045204A (en) | A kind of herb liquid and preparation method thereof for treating burn and scald | |
CN101658607A (en) | Cutaneous muscle regeneration dressing gauze and preparation method thereof | |
CN101049353A (en) | Lotion of medication for treating dermatophytosis | |
CN100350934C (en) | Baidianxiao treaditional Chinese medicine for treating vitiligo and preparation method thereof | |
CN1068785C (en) | Chinese patent medicine for external application for curing diseases of scald, burn and dermal ulcer | |
CN102688368B (en) | Traditional Chinese medicine for treating trauma hemostasis or telephium | |
CN1199669C (en) | Medicine for curing cervicitis and preparing method thereof | |
CN113262264A (en) | A Chinese medicinal composition for relieving pain and promoting granulation, and its preparation method | |
CN104623304A (en) | Lotion for treating chronic skin ulcer caused by damp-heat and toxicity accumulation and preparation method of lotion | |
CN105250525A (en) | Traditional Chinese medicine lotion for treating diabetic foot and preparation method thereof | |
CN105250712A (en) | Traditional Chinese medicine composition for treating bedsores | |
CN109464569A (en) | A kind of Chinese medicine composition that treating burn, ointment and preparation method thereof | |
CN106798364A (en) | A kind for the treatment of chilblain gloves lining cloth | |
CN101874847A (en) | A kind of compound traditional Chinese medicine for treating scald and preparation method thereof | |
CN105125926A (en) | Medical powder for treating burns and scalds and preparation method of medical powder | |
CN102846778B (en) | Chinese medicinal formulation for treating burn and scald and preparation method thereof | |
CN1686343A (en) | Chinese medicinal preparation for anti bacteria and promoting tissue regeneration | |
CN103432320A (en) | Externally used slough-removing tissue regeneration-promoting powder for facilitating healing of open wound, carbuncle, sore and ulceration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080716 |